SCN patient characteristics
| Patient ID . | Age, y . | Sex . | Diagnosis . | Cytogenetics . | G-CSF dose, μg/kg/per day . | G-CSF duration, y . |
|---|---|---|---|---|---|---|
| 12397 | 15 | M | AML (M5) | 45, XY, −7 | 1.9 | 6.3 |
| 17390 | 7.8 | F | AML (M2) | 46,XX,ins(1,?7)(q25;q31q36) t(8,21)(q22;qq22)[20] | 3.8 | 3.7 |
| 12374 | 49.3 | M | AML (M7) | 45, XY, −7, del(6)(q21) | 2.4 | 4.8 |
| 17392 | 5 | F | AML (M2) | 46, XY, inv (16), t(5:6)(q31:q27) | 13.5 | 3.7 |
| 12377 | 20.3 | F | MDS (RAEB) | 46, XX, add(2)(q37), add 7(q22) | 9 | 8 |
| 17393 | 18.3 | M | MDS | NA | 5 | 11.4 |
| 17394 | 13.4 | M | AML (M1) | 46, XY | 3.7 | 13.5 |
| 12400 | 7.8 | M | AML | 46, XY | 5.2 | 6.8 |
| 13462 | 16.8 | F | AML (M5) | 45, XX, −7/4n | 2.6 | 8.5 |
| 13464 | 2.9 | M | AML/B-ALL | 46 XY,add (21)(q22); XY, +21 | 10-120 | 2.8 |
| 13476 | 7 | F | AML (M0) | 45,XX,−7[12]/46,XX[11]. nuc ish (D7S486x1) | 0.72 | 6.8 |
| 13995 | 15.6 | F | AML (M2) | del(10)(q32) | 48 | 10.2 |
| 14251 | 11.8 | F | ALL | 48,XX,del(5)(q21q34),+21,+22[16]/46, XX[8] | 26 | 6.8 |
| 14252 | 7.4 | M | MDS | 47,XY,−7,+21,+21[9]/46, XY[5] | 18 | 4.4 |
| Patient ID . | Age, y . | Sex . | Diagnosis . | Cytogenetics . | G-CSF dose, μg/kg/per day . | G-CSF duration, y . |
|---|---|---|---|---|---|---|
| 12397 | 15 | M | AML (M5) | 45, XY, −7 | 1.9 | 6.3 |
| 17390 | 7.8 | F | AML (M2) | 46,XX,ins(1,?7)(q25;q31q36) t(8,21)(q22;qq22)[20] | 3.8 | 3.7 |
| 12374 | 49.3 | M | AML (M7) | 45, XY, −7, del(6)(q21) | 2.4 | 4.8 |
| 17392 | 5 | F | AML (M2) | 46, XY, inv (16), t(5:6)(q31:q27) | 13.5 | 3.7 |
| 12377 | 20.3 | F | MDS (RAEB) | 46, XX, add(2)(q37), add 7(q22) | 9 | 8 |
| 17393 | 18.3 | M | MDS | NA | 5 | 11.4 |
| 17394 | 13.4 | M | AML (M1) | 46, XY | 3.7 | 13.5 |
| 12400 | 7.8 | M | AML | 46, XY | 5.2 | 6.8 |
| 13462 | 16.8 | F | AML (M5) | 45, XX, −7/4n | 2.6 | 8.5 |
| 13464 | 2.9 | M | AML/B-ALL | 46 XY,add (21)(q22); XY, +21 | 10-120 | 2.8 |
| 13476 | 7 | F | AML (M0) | 45,XX,−7[12]/46,XX[11]. nuc ish (D7S486x1) | 0.72 | 6.8 |
| 13995 | 15.6 | F | AML (M2) | del(10)(q32) | 48 | 10.2 |
| 14251 | 11.8 | F | ALL | 48,XX,del(5)(q21q34),+21,+22[16]/46, XX[8] | 26 | 6.8 |
| 14252 | 7.4 | M | MDS | 47,XY,−7,+21,+21[9]/46, XY[5] | 18 | 4.4 |
All patients included in this table are white. The clinical status at the time the sample was obtained is shown, including the diagnosis, major cytogentic abnormality (if any), and duration and dose of G-CSF.
RAEB indicates refractory anemia with excess of blasts; NA, not available.